SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000936392-06-000738
Filing Date
2006-07-31
Accepted
2006-07-31 13:07:49
Documents
4
Period of Report
2006-07-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a22507e8vk.htm 8-K 13470
2 EXHIBIT 99.1 a22507exv99w1.htm EX-99.1 9014
3 EXHIBIT 99.2 a22507exv99w2.htm EX-99.2 1736
4 GRAPHIC a22507a2250700.gif GRAPHIC 2823
  Complete submission text file 0000936392-06-000738.txt   29965
Mailing Address
Business Address 11588 SORRENTO VALLEY ROAD SUITE 17 SAN DIEGO CA 92121 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 06990323
SIC: 2836 Biological Products, (No Diagnostic Substances)